The shareholders of
Right to attend the meeting
Shareholders who wish to attend the meeting must:
- be registered in their own name (not nominee registered) in the share register kept by
Euroclear Sweden AB on the record date for the meeting, i.e.Monday, April 8, 2024 , -
notify the Company of their participation so that the notification is received by the Company no later than
Friday, April 12, 2024 , to the address Ekeby Bruk 2N, 752 63 Uppsala or by e-mail to info@pharmacolog.se.
Nominee-registered shares
Shareholders whose shares are registered in the name of a nominee must, in order to be able to exercise their voting rights and participate in the meeting, temporarily register the shares in their own name in the share register maintained by
Proxies
Shareholders who intend to attend by proxy must issue a written and dated power of attorney for the proxy. The power of attorney must not have been issued earlier than five years before the date of the meeting. The original of the power of attorney and the registration certificate and other authorization documents evidencing the authorized representative of a legal entity shall be sent to the Company at the above address. The Company will provide a proxy form upon request and this is also available on the Company's website, www.pharmacolog.com, and will be sent to the shareholders who request it.
Number of shares and votes
At the time of issue of this notice, the Company has a total of 108,520,176 shares of series B and 0 shares of series A. Each Class B share represents one vote. The Company does not hold any own shares.
Proposal for the agenda
- Opening of the meeting and election of chairman of the meeting
- Preparation and approval of the voting list
- Approval of the agenda
- Election of one or two verifiers
- Examination of whether the meeting has been duly convened.
- The Board of Directors' report on the proposed new business, the new name and the resulting new Articles of Association.
-
Resolution on new Articles of
Association for the Company . - Closing of the meeting
Proposed resolutions
Item 1 - Election of chairman of the meeting
Item 7 - Resolution on new Articles of
The board of directors proposes that § 1 Company name in the Articles of Association shall read: "The company's company name is
The Board of Directors proposes that § 3 Operations shall read: "The company shall, through wholly and partly owned subsidiaries, develop, manufacture, market and sell products and solutions within the health care sector, and engage in other activities compatible therewith.
Otherwise, the Board proposes no changes to the Articles of Association.
Questions to the Board of Directors and the CEO
The Board of Directors and the CEO shall, if any shareholder so requests, and the Board of Directors believes that it can be done without significant damage to the Company, provide information on circumstances that may affect the assessment of an item on the agenda or the Company's financial situation, and the Company's relationship with another group company. Those who wish to submit questions in advance can do so to
In connection with the EGM, the Company will process personal data in accordance with its privacy policy, which is available on the Company's website, www.pharmacolog.com.
Uppsala in
The Board of Directors
For more information contact:
Email: lars.gusch@pharmacolog.com
Phone: +46 70-223 97 72
About Pharmacolog
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog's products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.
The following trademarks are owned and protected by
Further information regarding the company is available at https://pharmacolog.com/.
The company's Certified Adviser is
https://news.cision.com/pharmacolog/r/notice-to-extraordinary-general-meeting-in-pharmacolog-i-uppsala-ab--publ-,c3945658
https://mb.cision.com/Main/12317/3945658/2669228.pdf
https://news.cision.com/pharmacolog/i/klubba500x388,c3278153
(c) 2024 Cision. All rights reserved., source